Spanish Red Biotech Pipeline

Oryzon

Vafidemstat (ORY-2001) - CNS optimized LSD1 inhibitor

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: Schizophrenia (Negative Symptoms & Cognition) Clinical Trial "EVOLUTION" - recruiting
Phase: 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical